Kimberly-Clark’s Viva is launching limited-edition pink paper towels to raise funds for the McGrath Foundation.The ...
Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...
24/7 Wall St. on MSN
The 5 best S&P 500 dividend aristocrat stocks to buy before 2026
Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial ...
Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ending months of speculation about the future of the embattled maker of Tylenol, Band-Aid and Listerine. Even ...
WARREN — Although the company has not completed construction of its first building, Kimberly-Clark Corp. representatives are laying the groundwork needed for a new enterprise zone agreement to place a ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, Tylenol, is in the crosshairs of the White House. Kimberly-Clark said it would ...
This is read by an automated voice. Please report any issues or inconsistencies here. Kimberly-Clark is acquiring Kenvue for $48.7 billion, combining Tylenol, Kleenex, Band-Aid and Listerine into a ...
With well-known brands like Kleenex, Scott and Huggies, consumer goods company Kimberly-Clark announced it will acquire consumer health company Kenvue, whose portfolio includes Band-Aid, Listerine and ...
NEW YORK (Reuters) -Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, the United States, will keep growing even as ...
Kimberly-Clark will acquire Kenvue in a deal valued at nearly $49 billion, both companies announced Monday, combining the maker of Huggies diapers and Kleenex with the owner of Tylenol, which has ...
Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two companies announced Nov. 3. The companies in news releases billed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results